Díaz EER, Baranda VH

Language: Spanish
References: 12
Page: 506-511
PDF size: 742.06 Kb.

ABSTRACT

Introduction: kidney transplantation is the definitive therapy for patients with chronic kidney disease. Optimal fluid therapy has been shown to decrease delayed graft function after kidney transplantation, which has a significant incidence. Excessive infusion volume to the point of no further response to fluids can damage the endothelial glycocalyx and is no longer considered the best method. Therefore, obtaining adequate flow to maintain sufficient tissue perfusion without maximizing cardiac filling is considered a challenge. Material and methods: a retrospective, observational, non-problem sampling study was conducted in which the amount of fluid used during the transanesthetic period was determined, in addition to determining serum creatinine at 24 hours and seven days after kidney transplantation. Conclusions: fluid therapy that corresponds to a positive fluid balance during the transanesthetic period will favor the decrease of serum creatinine, having better results in living related donors compared to deceased donors, as well as a positive impact on early graft function.

REFERENCES

1. GBD 2017 Incidence and Injury Incidence and PrevalenceCollaborators. Global, regional, and national incidence, prevalence,and years lived with disability for 354 diseases and injuries for 195countries and territories, 1990-2017: a systematic analysis for theGlobal Burden of Disease Study 2017. Lancet. 2018; 392 (10159):1789-1858.

2. Comunicado de prensa núm. 538/19 31 de octubre de 2019. InstitutoNacional de Estadística Geografía e Informática. Disponible en:https://www.inegi.org.mx/contenidos/saladeprensa/boletines/2019/EstSociodemo/DefuncionesRegistradas2019.pdf

3. Calixto-Fernandes MH, Schricker T, Magder S, Hatzakorzian R.Perioperative fluid management in kidney transplantation: a blackbox. Crit Care. 2018; 22 (1): 14.

4. Bergman S, Feldman LS, Carli F, Anidjar M, Vassiliou MC, Andrew CG, et al.Intraoperative fluid management in laparoscopic live-donor nephrectomy:challenging the dogma. Surg Endosc. 2004; 18 (11): 1625-1630.

5. Trujillo J, Aristizábal N, Fonseca N. Lactato de Ringer versussolución salina normal para trasplante renal. Revisión sistemática ymetaanálisis. Rev Colomb Anestesiol. 2015; 43 (3): 194-203.

6. De Gasperi A, Narcisi S, Mazza E, Bettinelli L, Pavani M, Perrone L,et al. Perioperative fluid management in kidney transplantation: isvolume overload still mandatory for graft function? Transplant Proc.2006; 38 (3): 807-809.

7. Moreno-Ley PI, Cruz-Santiago J, Álvarez-Rangel LE, Bernáldez-GómezG, Meza-Jiménez G, Rivera-Luna EN. Desensibilización en trasplanterenal. Experiencia en el Hospital de Especialidades Centro MédicoNacional “La Raza” IMSS. Rev Mex Traspl. 2016; 5 (1): 6-14.

8. Schnuelle P, van der Woude J. Perioperative fluid management inrenal transplantation: a narrative review of the literature. Transpl Int.2006; 19 (12): 947-959.

9. Srivastava D, Sahu S, Chandra A, Tiwari T, Kumar S, Singh PK. Effectof intraoperative transesophageal Doppler-guided fluid therapyversus central venous pressure-guided fluid therapy on renal allograftoutcome in patients undergoing living donor renal transplant surgery:a comparative study. J Anesth. 2015; 29 (6): 842-849.

10. Gonzalez-Castro A, Ortiz-Lasa M, Peñasco Y, González C, Blanco C,Rodriguez-Borregan JC. Choice of fluids in the perioperative periodof kidney transplantation. Nefrologia. 2017; 37 (6): 572-578.

11. Weinberg L, Harris L, Bellomo R, Ierino FL, Story D, Eastwood G et al.Effects of intraoperative and early postoperative normal saline or Plasma-Lyte 148V R on hyperkalaemia in deceased donor renal transplantation:a double-blind randomized trial. BJA. 2017; 119 (4): 606-615.

12. Efune GE, Zerillo J, Zhou G, Mazzeffi MA, Demaria S, Wang C et al.Intravenous fluid management practices in kidney transplant patients:a multicenter observational cohort pilot study. Semin CardiothoracVasc Anesth. 2020; 24 (3): 256-264.